Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans

被引:50
作者
Broglio, F
Benso, A
Gottero, C
Prodam, F
Grottoli, S
Tassone, F
Maccario, M
Casanueva, FF
Dieguez, C
Deghenghi, R
Ghigo, E
Arvat, E
机构
[1] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, I-10124 Turin, Italy
[2] Univ Santiago de Compostela, Dept Internal Med, Santiago De Compostela, Spain
[3] Univ Santiago de Compostela, Dept Physiol, Santiago De Compostela, Spain
[4] Europeptides, Argenteuil, France
关键词
D O I
10.1046/j.1365-2265.2002.01595.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Ghrelin, a 28 amino acid peptide purified from the stomach and showing a unique structure with an n-octanoyl ester in serine-3 residue, is a natural ligand of the GH secretagogue (GHS) receptor (GHS-R) and strongly stimulates GH secretion. In humans, ghrelin is more potent than growth hormone-releasing hormone (GHRH) and non-natural GHS such as hexarelin. Moreover, ghrelin shows a true synergism with GHRH, has no interaction with hexarelin and, similarly to non-natural GHS, is partially refractory to the inhibitory effect of exogenous somatostatin (SS). Despite this evidence, the mechanisms underlying the GH-releasing effect of ghrelin in humans have not been fully clarified. SUBJECTS To this aim we enrolled six normal young volunteers [age (mean +/- SEM) 28.9 +/- 3.1 year; body mass index 22.3 +/- 1.0 kg/m(2)). DESIGN AND MEASUREMENTS In all subjects we studied the effects of glucose (OGTT, 100 g oral glucose at -45 min) or free fatty acids (FFA) load [lipid-heparin emulsion, Li-He, Intralipid 10% 250 ml + heparin 2500 U i.v. from -30 to +120 min] as well as of arginine (ARG, 0.5 g/kg infused from 0 to +30 min) on the GH response to human ghrelin (1.0 mug/kg i.v. at 0 min) administration. These results were compared with those obtained by studying the effects of OGTT, Li-He and ARG on the GH response to GHRH-29 (1.0 mug/kg i.v. at 0 min). RESULTS The GH response to ghrelin (auc<x> 5452.4 +/- 991.3 mug/l/h) was higher (P < 0.05) than that after GHRH (1519.4 +/- 93.3 μg/l/h). The GH response to GHRH was inhibited by OGTT (450.7 +/- 81.1 μg/l/h, </x> P < 0.05) and almost abolished by Li-He (230.0 +/- 63.6 μg/l/h, P < 0.05) while was markedly potentiated by ARG (2520.4 +/- 425.8 mug/l/h, P < 0.05). The GH response to GHRH + ARG, however, was lower (P < 0.05) than that to ghrelin alone. The GH response to ghrelin was blunted by OGTT (2153.1 +/- 781.9 mug/l/h, P < 0.05) as well as by Li-He (3158.8 +/- 426.7 μg/l/h, P < 0.05) but these responses remained higher (P < 0.05) than that to GHRH alone. On the other hand, ARG did not modify the GH response to ghrelin (6324.3 +/- 1275.5 μg/l/h). For GH 1 μg/l = 2 mU/l. CONCLUSIONS In humans, ghrelin exerts a strong stimulatory effect on GH secretion which is partially refractory to the inhibitory effect of both glucose and FFA load and is not enhanced by ARG. These factors almost abolish and potentiate, respectively, the GH response to GHRH, at least partially, via modulation of hypothalamic SS release. Thus, our findings agree with the hypothesis that ghrelin as well as non-natural GHS acts, at least partially, by antagonizing SS activity.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 49 条
[1]   EVIDENCE FOR A DIRECT PITUITARY INHIBITION BY FREE FATTY-ACIDS INVIVO GROWTH-HORMONE RESPONSES TO GROWTH HORMONE-RELEASING HORMONE IN THE RAT [J].
ALVAREZ, CV ;
MALLO, F ;
BURGUERA, B ;
CACICEDO, L ;
DIEGUEZ, C ;
CASANUEVA, FF .
NEUROENDOCRINOLOGY, 1991, 53 (02) :185-189
[2]   Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans [J].
Arvat, E ;
Di Vito, L ;
Broglio, F ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) :493-495
[3]   Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone [J].
Arvat, E ;
Maccario, M ;
Di Vito, L ;
Broglio, F ;
Benso, A ;
Gottero, C ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1169-1174
[4]   MODULATION OF GROWTH HORMONE-RELEASING ACTIVITY OF HEXARELIN IN MAN [J].
ARVAT, E ;
GIANOTTI, L ;
DIVITO, L ;
IMBIMBO, BP ;
LENAERTS, V ;
DEGHENGHI, R ;
CAMANNI, F ;
GHIGO, E .
NEUROENDOCRINOLOGY, 1995, 61 (01) :51-56
[5]   SEX-DIFFERENCES IN GROWTH-HORMONE (GH) SECRETION BY RATS ADMINISTERED GH-RELEASING HEXAPEPTIDE [J].
BERCU, BB ;
WEIDEMAN, CA ;
WALKER, RF .
ENDOCRINOLOGY, 1991, 129 (05) :2592-2598
[6]   GROWTH-HORMONE (GH)-RELEASING PEPTIDE STIMULATES GH RELEASE IN NORMAL MEN AND ACTS SYNERGISTICALLY WITH GH-RELEASING HORMONE [J].
BOWERS, CY ;
REYNOLDS, GA ;
DURHAM, D ;
BARRERA, CM ;
PEZZOLI, SS ;
THORNER, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :975-982
[7]   Unnatural growth hormone-releasing peptide begets natural ghrelin [J].
Bowers, CY .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1464-1469
[8]  
BROGLIO F, 2001, P 83 M END SOC DENV, P79
[9]   PHYSIOLOGY OF GROWTH-HORMONE SECRETION AND ACTION [J].
CASANUEVA, FF .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1992, 21 (03) :483-517
[10]   Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines [J].
Cassoni, P ;
Papotti, M ;
Ghè, C ;
Catapano, F ;
Sapino, A ;
Graziani, A ;
Deghenghi, R ;
Reissmann, T ;
Ghigo, E ;
Muccioli, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1738-1745